Immediate Impact
2 from Science/Nature 62 standout
Citing Papers
Global trends in incidence, death, burden and risk factors of early-onset cancer from 1990 to 2019
2023 Standout
Protein posttranslational modifications in health and diseases: Functions, regulatory mechanisms, and therapeutic implications
2023 Standout
Works of N. Botwood being referenced
Phase III Trial of FOLFOX plus Bevacizumab or Cediranib (AZD2171) as First-Line Treatment of Patients with Metastatic Colorectal Cancer: HORIZON III
2009
Gefitinib (IRESSA) in Patients of Asian Origin with Refractory Advanced Non-small Cell Lung Cancer: Subset Analysis from the ISEL Study
2006
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| N. Botwood | 309 | 331 | 88 | 119 | 19 | 511 | |
| J Lokich | 152 | 458 | 87 | 99 | 15 | 561 | |
| Rocco De Vivo | 164 | 162 | 104 | 77 | 24 | 413 | |
| John Syrios | 136 | 289 | 99 | 76 | 21 | 557 | |
| J.L. Lee | 173 | 288 | 60 | 135 | 14 | 459 | |
| Nobuya Hayashi | 294 | 174 | 60 | 62 | 31 | 515 | |
| P Vodvářka | 229 | 362 | 72 | 117 | 16 | 526 | |
| Karen Briscoe | 206 | 272 | 35 | 128 | 21 | 548 | |
| Burton Needles | 102 | 325 | 150 | 36 | 17 | 532 | |
| Lucia Bonomi | 212 | 248 | 17 | 107 | 22 | 419 | |
| K. Beerblock | 130 | 399 | 75 | 51 | 22 | 522 |
All Works
Loading papers...